| Brett J Davis, | |
|
62 S 950 W, Brigham City, UT 84302-4424 | |
| (435) 538-5063 | |
| (435) 538-5065 |
| Full Name | Brett J Davis |
|---|---|
| Gender | Male |
| Speciality | Counselor |
| Location | 62 S 950 W, Brigham City, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144657172 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brett J Davis, Po Box 526, Brigham City, UT 84302-0526 Ph: (435) 538-5063 | Brett J Davis, 62 S 950 W, Brigham City, UT 84302-4424 Ph: (435) 538-5063 |
News Archive
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating SGX942, a first-in-class innate defense regulator, as a treatment for oral mucositis in patients undergoing chemoradiation therapy for head and neck cancer.
Medical imaging is a notoriously data intensive field with its volume, variety and speed of data generation multiplying every day. Conventional tools are incapable of efficiently managing such large and complex datasets; posing limits on scalability, sustainability and usability. As the U.S. medical imaging field evolves from being not only data-intensive but also data-driven, big data tools are expected to better handle medical imaging, patient records, and improve workflow efficiency, diagnostic accuracy, treatment decisions and health management.
The long-term consequences of pneumonia can be more detrimental to a person's health than having a heart attack, according to joint research from the University of Michigan Health System and University of Washington School of Medicine.
Johnson & Johnson today announced that its Janssen Pharmaceutical Companies will invest $10 million in a new UK government-led global dementia discovery fund that will support innovative research to help find new ways to prevent and treat dementia and Alzheimer's disease.
New research from Cornell University indicates that pregnant women who increase choline intake in the third trimester of pregnancy may reduce the risk of the baby developing metabolic and chronic stress-related diseases like high blood pressure and diabetes later in life.
› Verified 4 days ago
Matthew Lamar Huff, Counselor Medicare: Not Enrolled in Medicare Practice Location: 82 S 800 W, Brigham City, UT 84302 Phone: 435-723-8548 Fax: 435-538-5066 | |
Shanua Buck, Counselor Medicare: Not Enrolled in Medicare Practice Location: 82 S 800 W, Brigham City, UT 84302 Phone: 435-723-8548 | |
Alexandra Rosales, Counselor Medicare: Not Enrolled in Medicare Practice Location: 971 S 800 W, Brigham City, UT 84302 Phone: 435-239-8445 | |
Tein Daniel Hawke, Counselor Medicare: Not Enrolled in Medicare Practice Location: 862 S Main Suite 4, Brigham City, UT 84302 Phone: 435-723-1799 | |
Jesus Franco, Counselor Medicare: Not Enrolled in Medicare Practice Location: 82 S 800 W, Brigham City, UT 84302 Phone: 435-723-8548 | |
Esmeralda Gil, Counselor Medicare: Not Enrolled in Medicare Practice Location: 971 S 800 W, Brigham City, UT 84302 Phone: 435-239-8445 | |
William Miller I, Counselor Medicare: Not Enrolled in Medicare Practice Location: 862 S Main Suite 4, Brigham City, UT 84302 Phone: 435-723-1799 |